Bionano Genomics, Inc. - SIC # 8092 - KIDNEY DIALYSIS CENTERS

Ticker Exchange SIC # Website Latest Ticker
BNGO Nasdaq 8092 www.bionano.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Bionano Genomics, Inc.

Bionano Recaps Global Momentum Behind Optical Genome Mapping at the 2025 Annual Meeting of the European Society of Human Genetics Held Recently in Milan, Italy - Jun 18th, 2025 6:00 am
Bionano Genomics Inc (BNGO) Q1 2025 Earnings Call Highlights: Navigating Revenue Challenges ... - May 15th, 2025 1:16 am
Bionano Reports First Quarter 2025 Results and Highlights Recent Business Progress - May 14th, 2025 2:01 pm
Bionano to Report First Quarter 2025 Financial Results and Host a Conference Call Webcast on May 14, 2025 - May 7th, 2025 2:01 pm
International Consortium for Optical Genome Mapping Publishes Expert Recommendations for Integration of OGM as a Standard-of-Care Cytogenetic Assay for Diagnostic Workflows in Blood Cancers - May 2nd, 2025 7:30 am
Bionano Announces Publication Showing OGM can Provide an Accurate and Cost-Effective Solution for Sizing Large Repeat Expansions in Constitutional Genetic Disease - Apr 23rd, 2025 6:00 am
Bionano Announces French Publication of an Effective Method for Analysis of Multiple Myeloma by OGM - Apr 8th, 2025 6:00 am
Analysts Are Upgrading Bionano Genomics, Inc. (NASDAQ:BNGO) After Its Latest Results - Apr 3rd, 2025 6:22 am
Bionano Genomics Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags - Apr 2nd, 2025 4:42 am
Bionano Genomics Inc (BNGO) Q4 2024 Earnings Call Highlights: Strategic Cost Reductions and ... - Apr 1st, 2025 1:04 am
Bionano Genomics (BNGO) Q4 2024 Earnings Call Transcript - Mar 31st, 2025 6:30 pm
Bionano Reports Fourth Quarter and Full-Year 2024 Results and Provides Revenue Outlook for 2025 - Mar 31st, 2025 2:01 pm
Study Using OGM in Neural Tube Defects Reveals Previously Unreported Variants and Candidate Genes with Potential Links to the Devastating Birth Defect - Mar 24th, 2025 6:00 am
Bionano Announces Extensive Lineup of Content at American College of Medical Genetics and Genomics (ACMG) 2025 Annual Meeting - Mar 18th, 2025 6:00 am
Bionano to Report Fourth Quarter and Full Year 2024 Financial Results and Host a Conference Call Webcast on March 31, 2025 - Mar 14th, 2025 6:00 am
Bionano Announces Publication Reporting First Use of OGM to Detect Chromoanagenesis, a Key Marker of Poor Prognosis in AML - Mar 13th, 2025 7:00 am
Bionano Announces Effective Date of Reverse Stock Split - Jan 22nd, 2025 2:05 pm
Bionano Announces Use of OGM in Preimplantation Genetic Testing as Part of Successful Live Birth to a Couple Experiencing Recurrent Pregnancy Loss - Jan 14th, 2025 6:00 am
Bionano Reports Preliminary Fourth Quarter and Full-Year 2024 Results - Jan 13th, 2025 6:00 am
Bionano Announces Publication Showing that OGM Identifies Variant that Indicates Use of Proven Therapy in Acute Promyelocytic Leukemia - Jan 7th, 2025 6:00 am